NeutriSci Engages Investor Relations Firm and Confirms Trading Date
(firmenpresse) - VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 12/03/14 -- NeutriSci International Inc. (TSX VENTURE: NU) (the "Company" or "NeutriSci"), formerly known as Disani Capital Corp. (formerly TSX-V: DSN.H) is pleased to announce that it has retained KIN Communications Inc. ("Kin") to provide investor relations services to the Company, subject to regulatory and TSX Venture Exchange approval.
The Company also confirms that its shares will resume trading under the new trading symbol ("NU") at the open of the market on December 04, 2014.
Kin will assist NeutriSci in increasing public awareness by managing the Company''s corporate communications, marketing endeavors, and ongoing engagement with shareholders, finance professionals, and media contacts.
Kin will be paid $90,000 plus GST for an initial term of 12 months, and $7,500 per month thereafter. Kin will also be granted 350,000 stock options of the Company, subject to regulatory approval, exercisable at $0.75 per share. The options will vest at a rate of 25% per quarter from the date of the grant and will be exercisable for a period of five years. The Company has been advised that Kin and its principals collectively own 231,666 shares, and 73,333 warrants, each warrant exercisable into one share at an exercise price of $1.00 per share, in the Company.
Kin is one of Canada''s leading full-service investor relations firms. Kin has a proven track record of generating interest in their clients, building an active shareholder base, and solidifying communications that differentiates clients from their peers.
For more information, please visit .
On Behalf of the Board of Directors of NEUTRISCI INTERNATIONAL INC.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.
About NeutriSci International Inc.: NeutriSci specializes in the innovation, production and formulation of nutraceutical products. Established in 2009, NeutriSci has focused on the development of several breakthrough nutraceutical products with an initial focus on areas such as heart and cholesterol health, sleep deprivation therapies, immune defense as well as men''s prostate and sexual health. NeutriSci continues to build strong relationships and distribution channels for its BluScience and Neu Energy™ products with retailers throughout the United States. NeutriSci is focusing efforts in strengthening sustainable sales models with convenience and drugstore chain retailers such as Walgreens, CVS, Rite Aid, 7-11 and Circle K. For more information, visit .
Contacts:
NeutriSci International Inc.
Glen Rehman
President
(403) 264-6320
Investor Relations Contact: KIN Communications Inc.
Fred Leigh
VP Investor Relations
1-866-684-6730
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 03.12.2014 - 15:05 Uhr
Sprache: Deutsch
News-ID 1322887
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
VANCOUVER, BRITISH COLUMBIA
Phone:
Kategorie:
Drugs
Anmerkungen:
Diese Pressemitteilung wurde bisher 162 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"NeutriSci Engages Investor Relations Firm and Confirms Trading Date
"
steht unter der journalistisch-redaktionellen Verantwortung von
NeutriSci International Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
